维普中文期刊产品整合服务
57篇 您的检索式:作者名="Santus P"
    题名 作者 年代 出处 被引量
1Tolyporphin: a natural product from cyanobacteria with potent photosensitizing activity against tumor cells in vitro and in vivo显示文摘Morliere P Maziere J C Santus R 1998Cancer Res1998,58,:1
2Bronchodilator effect of an inhaled comination therpy with salmeterol + fluticasone and formoterol + budesonide in patientswith COPD显示文摘Cazzula M Santus P Di Marco F 2003Respir Med2003,97,5:1
3Why use long acting bronchodilators in chronic obstructive lung diseases? An extensive review on formotcrol and sahneterol显示文摘Santus E Radovanovic D Paggiaro P 2015Eur J Intern Med2015,26,6:1
4UVA-induced lipid peroxidation in cultured human fibroblasts显示文摘Morliere P Moysan A Santus R 1991Biochem Biophysica Acta1991,1084,:1
5A pilot study to assess the effects of combining fluticasone propionate/salmeterol and tiotropium on the airflow obstruction of patients with severe to very severe COPD显示文摘Cazzola M Andò F Santus P 0,,:1
6Anxiety and depression in asthma 显示文摘Di Marco F ' Santus P Centanni S 2011Curr Opin Pulm Med2011,17,1:1
7Bronehodilating effect of oxitropium bromide in heart disease patients with exacerbations of COPD:double - blind, randomized, controlled study 显示文摘Centanni S Santus P 2002Respir Med2002,96,3:1
8Close correlation between anxi- ety, depression, and asthma control显示文摘Di Marco F Verga M Santus P 2010Respir Med2010,104,1:1
9Safety and pharmacological profile of tiotropium bromide显示文摘Santus P Di Marco F 2009Expert Opin Drug Saf2009,8,3:1
10The role of cefditoren in the treatment of lower community-acquired respiratory tract infections(LRTIs):from bacterial eradication to reduced lung inflammation and epithelial damage显示文摘Di Marco F Braido F Santus P 2014Eur Rev Med Pharmacol Sci2014,18,3:1
11Combination therapy with salmeterol+fluticasone and formoterol+budesonide in patients with COPD显示文摘Cazzola M Santus P di Marco F 2003Respir Med2003,97,:1
12Redox reactions of the urate radical/urate couple with the superoxide radical anion,the tryptophan neutral radical and selected flavonoids in neutral aqueous solutions 显示文摘 Patterson LK Filipe P 2001Free Radic Res2001,35,:1
13Stromelysin-1 polymorphism as a new potential risk factor in progression of chronic obstructive pulmonary disease显示文摘Santus P Casanova F Biondi M L 2009Monaldi Arch Chest Dis2009,71,1:1
14Doppler echocardiocardiographic assessment of effects of inhaled long-acting beta-2agonists on pulmonary pressure in COPD patients显示文摘Cazzola M Mantero A Santus P 2007Pulm Pharmacol Ther2007,20,3:1
15Lipid peroxidation and 5-lipoxygenase activity in chronic obstructive pulmonary disease显示文摘Santus P Sola A Carlucci P 2005A Am J Respir Crit Care Med2005,71,8:1
16Bronchodilation test in COPD:effect of inspiratory manoeuvre preceding forced expiration显示文摘Santus P Pecchiari M Carlucci P 2003Eur Respir J2003,21,1:1
17The role of cefditoren in the treatment of lower community-acquired respiratory tract infections (LRTIs): from bacterial eradication to re- duced lung inflammation and epithelial damage显示文摘Di Marco F Braido F Santus P 2014Eur Rev Med Pharmacol Sci2014,18,3:1
18Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronehitis显示文摘Blasi F Aliberti S Tarsia P Santus P Centanni S Allegra L 2007Int J Chron Obstruct Pulmon Dis2007,2,:1
19Understanding the bur- den of pneumococcal disease in adults 显示文摘Blasi F Mantero M Santus P 2012Clin Microbiol In- fect2012,18,5:1
20The pharmacodynamic effects of single inhaled doses of formoterol,tiotropium and their combination in patients with COPD显示文摘Cazzola M Di Marco F Santus P 2004Pulm Pharm Ther2004,17,1:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费